IRB Study Number 19-1155
Status Recruiting
Location Cleveland Clinic Main Campus
Institute Digestive Disease & Surgery Institute
Description
We invite you to take part in a research study because you have inflammatory bowel disease (IBD), including Crohn’s disease (CD), ulcerative colitis (UC), and Indeterminate Colitis (IBDU).
The purpose of this study is to collect information on patients with Inflammatory Bowel Disease to determine the natural course of the disease and to determine how procedures or treatments that may be recommended by your doctors may affect IBD and general health. Information about which treatments are being used and your response to these treatments will be collected to help researchers better understand how IBD is managed. In addition to participating in the main part of the study, we will ask if you agree to participate in three optional “sub-studies”.
Your participation in this research will last up to 5 years.
Inclusion Criteria
- Adults with a diagnosis of Ulcerative colitis (UC), Indeterminate colitis (IBDU), or Crohn's disease (CD) who have been prescribed any IBD treatment (before or after enrolling) as long as the treatment is not from a clinical trial.
- Have plans to continue management of IBD through future visits to Cleveland Clinic Main Campus.
Exclusion Criteria
- Inability to provide written informed consent.
- Being enrolled in any interventional trial or study for IBD treatment. Please note: You may be enrolled in other registries or studies where IBD treatment outcomes are being reported and/or observed.
- Have had prior abdominal colectomy for UC or IBDU.
